RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.

@article{Temming2005RGDbasedSF,
  title={RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.},
  author={K. Temming and R. Schiffelers and G. Molema and R. J. Kok},
  journal={Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy},
  year={2005},
  volume={8 6},
  pages={
          381-402
        }
}
  • K. Temming, R. Schiffelers, +1 author R. J. Kok
  • Published 2005
  • Biology, Medicine
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
    • During the past decade, RGD-peptides have become a popular tool for the targeting of drugs and imaging agents to alphavbeta3-integrin expressing tumour vasculature. RGD-peptides have been introduced by recombinant means into therapeutic proteins and viruses. Chemical means have been applied to couple RGD-peptides and RGD-mimetics to liposomes, polymers, peptides, small molecule drugs and radiotracers. Some of these products show impressive results in preclinical animal models and a RGD targeted… CONTINUE READING
    View on PubMed
    rug.nl
    394 Citations
    Highly Influencial Citations
    6
    Background Citations
    91
    Methods Citations
    11
    Results Citations
    1

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    394 Citations
    Citation Type

    Citation Type

    RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study
    • 10
    RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
    • 34
    Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    • 40
    cRGD functionalised nanocarriers for targeted delivery of bioactives
    • 10
    Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
    • 58
    • PDF
    Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
    • 47
    • PDF
    RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.
    • 556
    • PDF
    Nanoparticulate targeted drug delivery using peptides and proteins
    • 1
    αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
    • 32
    • PDF
    RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells.
    • 94

    References

    SHOWING 1-10 OF 261 REFERENCES
    Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    • 381
    • PDF
    Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
    • 109
    • PDF
    Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.
    • 182
    Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.
    • 144
    Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    • 229
    • PDF
    Peptide-targeted PEG-liposomes in anti-angiogenic therapy.
    • 78
    Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study
    • 79
    Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    • 107
    Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting.
    • 62
    Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation.
    • 236